RCUS
Arcus Biosciences, Inc.
NYSE · USHealthcareBiotechnology
$28.17+2.92%
Price as of Jul 20, 2026
RCUS capital
Arcus Biosciences, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.22x
- Net debt / equity
- -0.17x
- Debt / assets
- 0.11x
- Debt / EBITDA
- -0.34x
- Net debt / EBITDA
- 0.27x
Liquidity & coverage
- Current ratio
- 4.04x
- Quick ratio
- 4.04x
- Cash ratio
- 3.93x
- Interest coverage
- -18.09x
- EBITDA / interest
- -15.00x
- Working capital
- $635.0M
Cash & dividend
- FCF / debt
- -4.33x
- Cash flow / debt
- -4.32x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.